ICGex
Pierre Romero et al.
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
Nature Communications 2024, vol. 15, issue 1
doi: 10.1038/s41467-024-47701-x
Francesca Lucibello et al.
Divergent local and systemic antitumor response in primary uveal melanomas
Journal of Experimental Medicine 2024, vol. 221, issue 6
doi: 10.1084/jem.20232094
Hugo Croizer et al.
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Nature Communications 2024, vol. 15, issue 1
doi: 10.1038/s41467-024-47068-z
Vadim K. Karnaukhov et al.
Innate-like T cell subset commitment in the murine thymus is independent of TCR characteristics and occurs during proliferation
Proceedings of the National Academy of Sciences 2024, vol. 121, issue 14
doi: 10.1073/pnas.2311348121
Sara ANDJUS et al.
Pervasive translation of Xrn1-sensitive unstable long non-coding RNAs in yeast
RNA 2024
doi: 10.1261/rna.079903.123
Antoine Vasseur et al.
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Oncogene 2024, vol. 43, issue 16
doi: 10.1038/s41388-024-02986-6
Yuvia A Pérez-Rico et al.
Transcriptional perturbation of LINE-1 elements reveals theircis-regulatory potential
2024
doi: 10.1101/2024.02.20.581275
M. D. Huguet et al.
Transcriptomic basis of sex loss in the pea aphid
BMC Genomics 2024, vol. 25, issue 1
doi: 10.1186/s12864-023-09776-6
Monika Licaj et al.
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Nature Communications 2024, vol. 15, issue 1
doi: 10.1038/s41467-024-45595-3
Stephen J. Bagley et al.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Nature Cancer 2024
doi: 10.1038/s43018-023-00709-6